
Benjamin Layno
Examiner (ID: 1812, Phone: (571)272-4424 , Office: P/3711 )
| Most Active Art Unit | 3711 |
| Art Unit(s) | 3737, 3711, 3722, 3712, 2899, 3304 |
| Total Applications | 3510 |
| Issued Applications | 2709 |
| Pending Applications | 159 |
| Abandoned Applications | 647 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8239767
[patent_doc_number] => 20120148501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => 'RADIOLOGICAL IMAGE ENHANCEMENT WITH TANTALUM CLUSTERS'
[patent_app_type] => utility
[patent_app_number] => 12/962965
[patent_app_country] => US
[patent_app_date] => 2010-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5286
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12962965
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/962965 | RADIOLOGICAL IMAGE ENHANCEMENT WITH TANTALUM CLUSTERS | Dec 7, 2010 | Abandoned |
Array
(
[id] => 8482804
[patent_doc_number] => 20120282211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'ANTIBODIES AND CONJUGATES FOR MODULATORS OF ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 13/511598
[patent_app_country] => US
[patent_app_date] => 2010-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3825
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511598
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/511598 | ANTIBODIES AND CONJUGATES FOR MODULATORS OF ANGIOGENESIS | Nov 23, 2010 | Abandoned |
Array
(
[id] => 6101831
[patent_doc_number] => 20110165323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'Production method of dry water'
[patent_app_type] => utility
[patent_app_number] => 12/926497
[patent_app_country] => US
[patent_app_date] => 2010-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8911
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20110165323.pdf
[firstpage_image] =>[orig_patent_app_number] => 12926497
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/926497 | Production method of dry water | Nov 21, 2010 | Abandoned |
Array
(
[id] => 6024363
[patent_doc_number] => 20110052689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'SUSTAINED RELEASE OF GUAIFENESIN'
[patent_app_type] => utility
[patent_app_number] => 12/940781
[patent_app_country] => US
[patent_app_date] => 2010-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 31206
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052689.pdf
[firstpage_image] =>[orig_patent_app_number] => 12940781
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/940781 | SUSTAINED RELEASE OF GUAIFENESIN | Nov 4, 2010 | Abandoned |
Array
(
[id] => 9139788
[patent_doc_number] => 08580245
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-12
[patent_title] => 'Compositions and methods for treating and preventing cardiomyopathy and heart disease'
[patent_app_type] => utility
[patent_app_number] => 12/915352
[patent_app_country] => US
[patent_app_date] => 2010-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12888
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12915352
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/915352 | Compositions and methods for treating and preventing cardiomyopathy and heart disease | Oct 28, 2010 | Issued |
Array
(
[id] => 8509209
[patent_doc_number] => 20120308616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-06
[patent_title] => 'SUBMICRO EMULSION OF PACLITAXEL USING STEROID COMPLEX AS INTERMEDIATE CARRIER'
[patent_app_type] => utility
[patent_app_number] => 13/505168
[patent_app_country] => US
[patent_app_date] => 2010-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11822
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505168
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/505168 | SUBMICRO EMULSION OF PACLITAXEL USING STEROID COMPLEX AS INTERMEDIATE CARRIER | Oct 27, 2010 | Abandoned |
Array
(
[id] => 8421842
[patent_doc_number] => 08278330
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-02
[patent_title] => 'Short duration depot formulations'
[patent_app_type] => utility
[patent_app_number] => 12/924441
[patent_app_country] => US
[patent_app_date] => 2010-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17989
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12924441
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/924441 | Short duration depot formulations | Sep 26, 2010 | Issued |
Array
(
[id] => 8442652
[patent_doc_number] => 20120259267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'Chemically Amplified Response Strategies for Medical Sciences'
[patent_app_type] => utility
[patent_app_number] => 13/496486
[patent_app_country] => US
[patent_app_date] => 2010-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 12665
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496486
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/496486 | Nanocarriers with multi-photon response elements | Sep 22, 2010 | Issued |
Array
(
[id] => 5993618
[patent_doc_number] => 20110015271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'TOPICAL NEPAFENAC FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/888631
[patent_app_country] => US
[patent_app_date] => 2010-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1702
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20110015271.pdf
[firstpage_image] =>[orig_patent_app_number] => 12888631
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/888631 | Topical nepafenac formulations | Sep 22, 2010 | Issued |
Array
(
[id] => 6344102
[patent_doc_number] => 20100330174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'BETAINE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/868592
[patent_app_country] => US
[patent_app_date] => 2010-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18533
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0330/20100330174.pdf
[firstpage_image] =>[orig_patent_app_number] => 12868592
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/868592 | BETAINE COMPOSITIONS | Aug 24, 2010 | Abandoned |
Array
(
[id] => 8370211
[patent_doc_number] => 20120219596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'INJECTABLE FORMULATION FOR TREATMENT AND PROTECTION OF PATIENTS HAVING AN INFLAMMATORY REACTION OR AN ISCHEMIA-REPERFUSION EVENT'
[patent_app_type] => utility
[patent_app_number] => 13/387838
[patent_app_country] => US
[patent_app_date] => 2010-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7119
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13387838
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/387838 | INJECTABLE FORMULATION FOR TREATMENT AND PROTECTION OF PATIENTS HAVING AN INFLAMMATORY REACTION OR AN ISCHEMIA-REPERFUSION EVENT | Jul 26, 2010 | Abandoned |
Array
(
[id] => 8158289
[patent_doc_number] => 20120100077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'MIXTURE OF AMPHIPATHIC MOLECULES AND METHOD FOR MODIFYING CELL MEMBRANES BY MEANS OF FUSION'
[patent_app_type] => utility
[patent_app_number] => 13/261122
[patent_app_country] => US
[patent_app_date] => 2010-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 9973
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20120100077.pdf
[firstpage_image] =>[orig_patent_app_number] => 13261122
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/261122 | MIXTURE OF AMPHIPATHIC MOLECULES AND METHOD FOR MODIFYING CELL MEMBRANES BY MEANS OF FUSION | Jul 7, 2010 | Abandoned |
Array
(
[id] => 5929841
[patent_doc_number] => 20110039800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'PROLONGED RELEASE BIOADHESIVE THERAPEUTIC SYSTEMS'
[patent_app_type] => utility
[patent_app_number] => 12/830090
[patent_app_country] => US
[patent_app_date] => 2010-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9306
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039800.pdf
[firstpage_image] =>[orig_patent_app_number] => 12830090
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/830090 | Prolonged release bioadhesive therapeutic systems | Jul 1, 2010 | Issued |
Array
(
[id] => 6234995
[patent_doc_number] => 20100266699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'Pharmaceutical Suspensions and Related Methods'
[patent_app_type] => utility
[patent_app_number] => 12/827107
[patent_app_country] => US
[patent_app_date] => 2010-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7826
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20100266699.pdf
[firstpage_image] =>[orig_patent_app_number] => 12827107
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/827107 | Pharmaceutical Suspensions and Related Methods | Jun 29, 2010 | Abandoned |
Array
(
[id] => 6503002
[patent_doc_number] => 20100260698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'Anhydrous Antiperspirant Compositions with Improved Active Substance Release'
[patent_app_type] => utility
[patent_app_number] => 12/823484
[patent_app_country] => US
[patent_app_date] => 2010-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17098
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20100260698.pdf
[firstpage_image] =>[orig_patent_app_number] => 12823484
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/823484 | Anhydrous Antiperspirant Compositions with Improved Active Substance Release | Jun 24, 2010 | Abandoned |
Array
(
[id] => 6518101
[patent_doc_number] => 20100261748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'STABLE LORATADINE SPILL RESISTANT FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 12/823230
[patent_app_country] => US
[patent_app_date] => 2010-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4035
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20100261748.pdf
[firstpage_image] =>[orig_patent_app_number] => 12823230
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/823230 | STABLE LORATADINE SPILL RESISTANT FORMULATION | Jun 24, 2010 | Abandoned |
Array
(
[id] => 9323666
[patent_doc_number] => 08658687
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-25
[patent_title] => 'Injectable formulations containing asenapine and method of treatment using same'
[patent_app_type] => utility
[patent_app_number] => 13/378118
[patent_app_country] => US
[patent_app_date] => 2010-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 23
[patent_no_of_words] => 10412
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13378118
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/378118 | Injectable formulations containing asenapine and method of treatment using same | Jun 23, 2010 | Issued |
Array
(
[id] => 8220718
[patent_doc_number] => 20120134921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'SOLID COMPOSITIONS COMPRISING 5-AMINOLEVULINIC ACID'
[patent_app_type] => utility
[patent_app_number] => 13/377692
[patent_app_country] => US
[patent_app_date] => 2010-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14457
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13377692
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/377692 | SOLID COMPOSITIONS COMPRISING 5-AMINOLEVULINIC ACID | Jun 10, 2010 | Abandoned |
Array
(
[id] => 10857016
[patent_doc_number] => 08883209
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-11
[patent_title] => 'Pharmaceutical solid dispersions'
[patent_app_type] => utility
[patent_app_number] => 12/760393
[patent_app_country] => US
[patent_app_date] => 2010-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19652
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 285
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12760393
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/760393 | Pharmaceutical solid dispersions | May 24, 2010 | Issued |
Array
(
[id] => 9648105
[patent_doc_number] => 08802115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-12
[patent_title] => 'Solid forms for tissue repair'
[patent_app_type] => utility
[patent_app_number] => 13/378458
[patent_app_country] => US
[patent_app_date] => 2010-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 34
[patent_no_of_words] => 26526
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13378458
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/378458 | Solid forms for tissue repair | May 22, 2010 | Issued |